Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT05770193
Eligibility Criteria:
Inclusion Criteria:
1. People who have a history of probable or confirmed SARS-CoV-2 infection; usually within three months from the onset of COVID-19, with symptoms and effects that last for at least two months.
2. Aged 18-45 years old.
3. Non-hospitalized.
4. Both sexes will be included.
5. Body mass index (BMI) range from (18.5 to 24.9 kg/m2).
6. Patients with low to moderate physical activity, according to the International Physical Activity Questionnaire (IPAQ) Arabic version.
7. Patients with grade 2 or higher on Modified Medical research council (Dyspnea Scale).
8. Able to read and write.
9. Willing and able to complete study procedures. -
Exclusion Criteria:
* 1\. Patients on medications that would influence exercise performance such as beta-blockers or antiretroviral therapy.
2\. Enrolled in another interventional clinical research trial in the previous 30 days.
3\. Pregnancy. 4. Had significant hepatic or renal dysfunction. 5. New onset of arrhythmia and myocardial ischemia. 6. Hospitalized. 7. Cardiac disease, chronic respiratory disease, active infection, severe endocrine or metabolic diseases.
8\. Cognitive impairment. 9. Patients with red flag indicators such as chest pain, critical drop in oxygen saturation, musculoskeletal or neurologic limitations, and unconscious patients.
10\. Contraindications of using kinesio tape as Malignancy, Infection, cellulitis, Open Wound, DVT, and Previous allergic reaction to kinesio tape
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT05770193
Study Brief:
Protocol Section:
NCT05770193